A Phase II Study to Evaluate the Efficacy of UF-KURE19 Cells in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphomas

Clinical trial NCT07713459 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07713459
Sponsor: Kure Cells, INC
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Lymphoma Nonhodgkin Marginal Zone B Cell Lymphoma Diffuse Large B Cell Lymphoma (DLBCL)Follicular B-cell Non-Hodgkin's Lymphoma CAR T Cell Therapy

Start date: 2026-08-31
Primary completion: 2029-08-31
Enrollment: 105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.